NovaBridge Biosciences
NBP
$2.06
-$0.04-1.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 12/31/2024 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.64% | 37.83% | -- | -- | -- |
| Total Receivables | 93.63% | 18.11% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.69% | 18.44% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 99.10% | -- | -- | -- | -- |
| Total Current Assets | -6.55% | 38.85% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -6.55% | 38.85% | -- | -- | -- |
| Net Property, Plant & Equipment | -6.82% | -6.39% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 144.95% | -5.82% | -- | -- | -- |
| Total Assets | -6.09% | 34.20% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 109.53% | 23.64% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.18% | 2.23% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 27.66% | -- | -- | -- | -- |
| Total Other Current Liabilities | 27.66% | -- | -- | -- | -- |
| Total Current Liabilities | 67.13% | 119.03% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | 67.13% | 119.03% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.45% | -8.56% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 59.94% | 85.41% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 0.26% | 4.30% | -- | -- | -- |
| Retained Earnings | -2.37% | -0.53% | -- | -- | -- |
| Treasury Stock & Other | -3.04% | 19.79% | -- | -- | -- |
| Total Common Equity | -10.80% | 31.61% | -- | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.80% | 31.61% | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.80% | 31.61% | -- | -- | -- |
|
|
|||||